Subjects With Clinical Indication for PET/CT Clinical Trial
— PET/MR_ZURICHOfficial title:
Clinical Evaluation of an Integrated PET/MRI System
| Verified date | January 2019 |
| Source | GE Healthcare |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Interventional |
The investigational PET/MRI scanner, including attenuation correction method, is capable of producing diagnostic quality images and appropriate device functionality per user feedback.
| Status | Completed |
| Enrollment | 62 |
| Est. completion date | August 2014 |
| Est. primary completion date | August 2014 |
| Accepts healthy volunteers | No |
| Gender | All |
| Age group | 18 Years and older |
| Eligibility |
Inclusion Criteria: 1. Subject must have a clinical indication for a PET/CT exam 2. Subject must be at least eighteen (18) years of age; and 3. Female subjects that are determined to be non-pregnant by a physician investigator or are demonstrated non-pregnant by negative urine pregnancy test administered within the 24 hour period before PET/CT imaging; and 4. Subject must be able to hear and understand instructions without assistive devices; and 5. Subject must provide written informed consent; and 6. Subject has the necessary mental capacity to understand instructions, and is able to comply with protocol requirements; and 7. Subject is able to remain still for duration of imaging procedure (approximately 60 minutes total for PET/MRI); and 8. Subject must be able to participate in a PET/MR imaging session within 2 hours of concluding their PET/CT exam and within 4 hours of PET radiotracer administration. Exclusion Criteria: 1. Subjects who have any axial diameter larger than 55 cm; or 2. Subjects with a weight greater than 227 kgs; or 3. Subjects that have metallic/conductive or electrically/magnetically active implants without MR Safe or MR Conditional labeling, with the exception of dental devices/fillings, surgical clips, and surgical staples determined to be safe for MRI scanning by a physician investigator; or 4. Subjects that have implants with MR Unsafe labeling; or 5. Subjects that have implants labeled as MR Conditional by the manufacturer for which the allowable conditions are not expected to be achieved by the MR/PET environment or scan protocol ; or 6. Subjects who have a contraindication to MRI according to the screening policy of the participating site |
| Country | Name | City | State |
|---|---|---|---|
| Switzerland | UniversitätsSpital Zürich | Zurich |
| Lead Sponsor | Collaborator |
|---|---|
| GE Healthcare |
Switzerland,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Number Usable PET/MRI Image Sets | The number PET/MRI image sets determined usable by a radiologist on a yes/no binary scale | 1 day | |
| Primary | Number of Diagnostic Quality Images | Number of images sets deemed diagnostic quality by the investigator | 1 day |